Efficacy Study of the Effect of Budesonide on Emphysema
NCT00232674
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG:
Pulmicort (budesonide) Turbuhaler
Sponsor
AstraZeneca